Core Technology Platforms
HAUUL BIO's cell therapy product platform technology is a “non-viral universal CAR cell therapy product development technology” that overcomes the limitations of existing cell therapy products and makes improvements in regard to safety, cost, treatment timing and customization, etc. required from the patient’s point of view. Based on the innovative cell therapy product platform, HAUUL Bio will grow into a leading company in the global biopharmaceutical field, and ultimately do our best for the balance between human health and happy life.
Improving human cancer treatment through extensive anticancer treatment researchthat can simplify the manufacturing processes and therapies
Improving human cancer treatment through extensive anticancer treatment researchthat can simplify the manufacturing processes and therapies
The recombinant fusion protein rCAR, MHCT
Customized for a variety of anti-cancer targets that can be manufacture generic off-the-shelf drug(Off-the-shelf)
scFv stock, Multiple CAR system
Switchable universal CAR
Versatile tandem CAR system
Platform technology for ADC grafted immune cell development
One Step - Chemotherapy + Immunotherapy
Patent status(Domestic)
Patent status(Overseas country)
